Beth P. Goldstein

Anidulafungin versus Fluconazole for Invasive Candidiasis

Annette C. Reboli, Coleman Rotstein, Peter G. Pappas et al. · New England Journal of Medicine · 2007 · 888 citations · Full text

Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens

Issam Raad, Rabih O. Darouiche, José A. Vázquez et al. · Clinical Infectious Diseases · 2005 · 292 citations · Full text

A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis

David S. Krause, A. E. Simjee, C.E.J. Van Rensburg et al. · Clinical Infectious Diseases · 2004 · 243 citations · Full text

Antifungal Agent, Antifungal Agents, Double-blind Trial +10

Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections

Elyse Seltzer, MaryBeth Dorr, Beth P. Goldstein et al. · Clinical Infectious Diseases · 2003 · 233 citations

Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. I. Isolation and characterization.

Enrico Selva, G. BERETTA, Nicoletta Montanini et al. · The Journal of Antibiotics · 1991 · 182 citations · Full text